Trial
NCT03868540
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Healthy
Intervention
BI 1291583
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-13